Picture of Integrated Pharmaceuticals logo

INTP Integrated Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Integrated Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2003
December 31st
2004
December 31st
2005
December 31st
2006
December 31st
2007
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10KSB10KSB10KSB10KSB10KSB
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.2-7.49-3.85-2.14-1.83
Depreciation
Non-Cash Items0.474.691.360.5760.316
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.2590.065-0.1040.061-0.125
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-0.446-2.5-2.07-0.96-1.1
Capital Expenditures-0.217-2.27-0.199-0.069-0.018
Purchase of Fixed Assets
Other Investing Cash Flow Items0.1850-0.064-0.0580.006
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-0.032-2.27-0.263-0.127-0.012
Financing Cash Flow Items-0.004-0.005-0.00300
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.7215.981.051.780.307
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.2441.21-1.280.69-0.806